About Us

Our Founder
Dr. Inderpal Randhawa

Dr. Inderpal Randhawa is a leading clinical academic scientist with five board certifications in transplant immunology, allergy, pulmonology, pediatrics, and internal medicine. Early in his career, Dr. Randhawa began to question conventional protocols for the treatment of life-threatening food allergies. Distressed by watching parents suffer the loss of a child to fatal allergic reactions, he proposed to find groundbreaking solutions and change the status quo. His early experience in lung transplant immunology coupled with his collaboration with national allergy and immunology specialists, led him to develop the safe, targeted solutions now offered through the Food Allergy Institute (FAI).

FAI was founded in 2015 by Dr. Inderpal Randhawa, the Food Allergy Institute is a cutting-edge clinical care and research center that is revolutionizing food allergy treatment.

Our Research

We Are Serious About Biotech Research & Artificial Intelligence

The Food Allergy Institute has the highest global success rate of disease remission for pediatric patients with food allergies.

We are able to achieve this level of precision based on over a decade of technological and research advancement, resulting in the first ever Cybernetics Food Anaphylaxis Panel.

The Cybernetics Food Anaphylaxis Panel

The Cybernetics Food Anaphylaxis Panel is the first diagnostic platform of its kind, combining applied mathematics, machine learning models, and highly complex diagnostic evaluations of the trillions of food anaphylaxis biomarkers we’ve collected. This data driven approach is the core of the Tolerance Induction Program™ (TIP).

Learn More About TIP

Our Mission

The Food Allergy Institute (FAI) is the largest food allergy treatment center of its kind. Through our unique approach to food allergy treatment, our Tolerance Induction Program™ (TIP) helps us drive our mission for all children who suffer from food allergies to safely eat whatever they want.

We are a division of the Translational Pulmonary and Immunology Research Center (TPIRC), a non-profit clinical care and research center that focuses on the development of cutting-edge, individualized treatment protocols for rare and orphan diseases utilizing comprehensive diagnostic tools and patient-driven research.